A California-based biotech company is already stealing the show during Wednesday’s premarket after the company announced a CEO transition and an estimated 83% reduction in...

To read the full story on AllPennyStocks.com, click here.

Kronos Bio (NASDAQ:KRON)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Kronos Bio
Kronos Bio (NASDAQ:KRON)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Kronos Bio